Net Cash Provided by (Used in) Operating Activities |
-19.1M |
USD |
-49.8% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
116M |
USD |
-42.9% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-56M |
USD |
+60.1% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
49.7M |
shares |
+21.7% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
41.1M |
USD |
-18.7% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
67.9M |
USD |
-32.9% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
31.5M |
USD |
+144% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
31.5M |
USD |
+144% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
7.89M |
USD |
+37.5% |
Q4 2023 |
FY 2023 |
Unrecognized Tax Benefits |
1.08M |
USD |
+312% |
Q4 2023 |
FY 2023 |
Additional Paid in Capital |
487M |
USD |
+34.4% |
Q2 2024 |
Q2 2024 |
Depreciation, Depletion and Amortization |
8K |
USD |
|
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Share-based Payment Arrangement, Expense |
8.1M |
USD |
+233% |
Q2 2024 |
Q2 2024 |